Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-17 Sale |
2024-07-19 6:18 pm |
ACELYRIN Inc. | SLRN | Becker Daniel J. Director |
1 | $6.86 | $7 | 2,999 (Direct) |
View |
| 2023-05-09 Purchase |
2023-05-11 9:02 pm |
ACELYRIN Inc. | SLRN | Becker Daniel J. Director |
3,000 | $18 | $54,000 | 26,243 (Direct) |
View |
| 2021-06-01 Purchase |
2021-06-01 9:50 pm |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
5,000 | $16 | $80,000 | 68,000 (Direct) |
View |
| 2020-11-19 Purchase |
2020-11-23 5:30 pm |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director |
197,716 | $15.12 | $2,989,466 | 2,827,883 (Indirect) |
View |
| 2020-11-17 Purchase |
2020-11-19 8:15 pm |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director |
29,394 | $15.29 | $449,400 | 2,630,167 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 7:39 pm |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner |
723,222 | $18 | $13,017,996 | 2,615,770 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-07 Option Award |
2024-06-11 7:14 pm |
N/A 2034-06-06 |
ACELYRIN Inc. | SLRN | Becker Daniel J. Director |
92,158 | $0 | 92,158 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-26 7:15 pm |
N/A 2033-06-21 |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2023-05-09 Other |
2023-05-11 9:02 pm |
N/A 2033-05-03 |
ACELYRIN Inc. | SLRN | Becker Daniel J. Director |
46,486 | $0 | 26,243 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-04 8:11 pm |
N/A 2033-05-03 |
ACELYRIN Inc. | SLRN | Becker Daniel J. Director |
23,243 | $0 | 23,243 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-23 6:08 pm |
N/A 2032-06-20 |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
28,700 | $0 | 28,700 (Direct) |
View |
| 2021-05-26 Option Award |
2021-06-01 9:50 pm |
N/A 2031-05-25 |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
63,000 | $0 | 68,000 (Direct) |
View |
Ownership |
2021-05-26 9:01 pm |
N/A 2031-05-22 |
Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director |
0 | $0 | 63,000 (Direct) |
View |
| 2021-04-01 Equity Swap |
2021-04-01 7:49 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director |
2,828,883 | $60 | 0 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:24 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director |
667,600 | $100 | 0 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 7:39 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner |
11,458,013 | $0 | 2,615,770 (Indirect) |
View |
| 2020-07-17 Option Award |
2020-07-21 7:39 pm |
N/A 2030-07-16 |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner |
13,997 | $0 | 2,615,770 (Direct) |
View |
Ownership |
2020-07-16 8:16 pm |
N/A N/A |
Pandion Therapeutics Inc. | PAND | Becker Daniel J. Director 10% Owner |
0 | $0 | 1,878,551 (Indirect) |
View |
| 2020-06-04 Option Award |
2020-06-08 8:03 pm |
N/A 2030-06-03 |
Principia Biopharma Inc. | PRNB | Becker Daniel J. Director |
10,240 | $0 | 10,240 (Direct) |
View |